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Abstract
Introduction. Syncope represents a relatively atypical
symptom of acute coronary syndrome. Syncope itself does
not provide enough information to indicate an acute coro-
nary event, especially a lesion of the left main coronary ar-
tery, without malignant rhythm and conduction disorders.
Case report. A male patient, aged 63, was admitted to the
intensive cardiac care unit because of a short loss of con-
sciousness, in sinus tachycardia, with signs of acute heart
failure and being hypotensive. Electrocardiogram showed a
possible acute anterior myocardial infarction, followed by
cardiogenic shock and emergency coronary angiography
(subocclusive ostial lesion of the left main coronary artery)
and primary percutaneous coronary intervention with intra-
aortic balloon pump therapy was performed. A direct drug
eluting stent was implanted with the optimal primary result.
Conclusion. The prompt diagnosis, especially in such
relatively atypical clinical presentation, reperfusion therapy
with primary percutaneous coronary intervention in acute
myocardial infarction complicated by cardiogenic shock,
contribute to the improvement in the survival rate and pa-
tient's quality of life. This case report is clinically educative
due to relatively atypical presentation and performed in-
terventions.
Key words:
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Apstrakt
Uvod. Sinkopa predstavlja relativno netipiÿan simptom
akutnog koronarnog sindroma. Sama sinkopa ne pruža do-
voljno informacija za dijagnozu akutnog koronarnog doga-
Āaja, naroÿito lezije  glavnog stabla leve koronarne arterije,
bez malignih poremeýaja ritma i provoĀenja. Prikaz boles-
nika. Bolesnik, star 63 godine, primljen je u jedinicu inten-
zivne kardiološke nege zbog kratkotrajnog gubitka svesti, u
sinus tahikardiji, sa znacima akutne srÿane slabosti, hipoten-
zivan. Elektrokardiogram je pokazivao suspektne znake za
razvoj akutnog infarkta miokarda prednjeg zida. Zbog toga,
kao i zbog razvoja poÿetnog kardiogenog šoka, indikovana
je i uraĀena urgentna koronarografija (subokluzivna lezija
ostijuma glavnog stabla leve koronarne arterije) i primarna
perkutana koronarna intervencija sa implantiranom intraa-
ortnom balon pumpom. Direktno je ugraĀen stent obložen
lekom sa optimalnim primarnim rezultatom. Zakljuÿak.
Brza dijagnoza, naroÿito sa ovakvom relativno atipiÿnom
kliniÿkom slikom, brza primena reperfuzione terapije u vidu
primarne perkutane koronarne intervencije u akutnom in-
farktu miokarda komplikovanim kardiogenim šokom, dop-
rinosi poboljšanju  preživljavanja i kvalitetu života bolesni-
ka. Ovaj prikaz bolesnika kliniÿki je pouÿan zbog relativno
atipiÿne prezentacije i izvršenih intervencija.
Kljuÿne reÿi:
infarkt miokarda; sinkopa; šok, kardiogeni;
angiografija koronarnih arterija; stentovi, lekom
obloženi.
Introduction
Syncope is a transient loss of consciousness precipi-
tated by cerebral hypoperfusion, which is associated with
the absence of postural tone and usually followed by a
complete recovery within a few minutes. This clinical con-
dition is a common medical problem with an estimated in-
cidence of per 1,000 persons per year and accounts for 1%
of emergency department visits and 6% of all hospital ad-
missions 
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Syncope represents a relatively atypical symptom of
acute coronary syndrome. Only 3.1% patients with syncope
were diagnosed with acute myocardial infarction 
2. Syncope
itself does not provide enough information to indicate an
acute coronary event, especially a lesion of the left main
coronary artery, without malignant rhythm and conduction
disorders. Many of the missed diagnoses included syncope
that resulted in medico-legal action involved. Therefore, es-
tablishing the diagnosis of syncope is important so that spe-
cific treatment can be administered to prevent future recur-
rences and eliminate the underlying predisposing disease.
Treatment of unprotected stenosis of the left main coro-
nary artery (LMCA) still remains a challenge for interven-
tional cardiologists. According to the current recommenda-
tions of the American Heart Association (AHA) and Ameri-
can College of Cardiology (ACC), unprotected LMCA ste-
nosis represents an indication for cardio-surgical treatment,
except in special situations where interventional cardiology
has its place 
3. Some of them are ostial lesion of the left main
stem, proximal lesion of the left main stem, acute myocardial
infarction, and initial and developed cardiogenic shock 
3.
According to current recommendations, the patients with
acute myocardial infarction (AMI), complex mechanical
complications or cardiogenic shock are supported using in-
tra-aortic balloon pump (IABP) 
4. Nowadays it is recom-
mended that even percutaneous coronary intervention (PCI)
on LMCA is performed with the support of IABP or other
circulatory support 
5.
For this reason, we presented a patient with syncope
and acute myocardial infarction with incipient cardiogenic
shock, diagnosed with unprotected ostial lesion of the left
main coronary artery.
Case report
A male patient, aged 63, was admitted to the intensive
cardiac care unit for a short loss of consciousness, without
chest pain. There was no history of previous syncopal or pre-
syncopal states or ischemic heart disease symptoms. Risk
factors for ischemic heart disease were hypertension and
smoking. At admission, the patient was conscious, hypoten-
sive with blood pressure of 90/60 mmHg, with signs of acute
heart failure and sinus tachycardia – heart rate of about
100/min, without malignant rhythm and conduction disor-
ders. Electrocardiogram registered signs of possible acute
anterior myocardial infarction, with incomplete left bundle
branch block (LBBB) and first degree heart (AV) block
(Figure 1). The initial laboratory tests showed increased val-
ues of myoglobin (261 ng/mL, reference values up to 107
ng/mL)‚ whereas the levels of hs troponin and creatine ki-
nase-MB (CK-MB) were within the reference range, due to
patient’s early presentation. Initial echocardiographic exami-
nation showed ischemic cardiomyopathy with ejection frac-
tion (EF) of 50%, and inferolateral basal and medial hypoki-
nesia, apical anterior, basal inferior and medial anterior aki-
nesia, with hyperkinetic movements of other segments. Soon
after admission, the state of the patient worsened and the first
signs of cardiogenic shock were registered (the mean arterial
pressure – MAP of 60 mmHg, diuresis 30 mL/h). For this
reason, the patient was initially administered midazolam, and
the sedation was later maintained using propofol, and was
supported with invansive mechanical ventilation (IMV) in
the intermittent positive pressure ventilation (IPPV) mode
with PEEP (positive end-expiratory pressure) 5 cm H2O. The
patient was treated with dual antiplatelet therapy (aspirin 300
mg, clopidogrel 600 mg), statin 20 mg  through nasogastric
tube,  heparin (1,000 IU/h), and inotropic stimulation with
dopamine 8 mcg/kg/min. Clinical status, electrocardio-
graphic changes, increased level of myoglobin, and echocar-
diographic findings gave indications for emergency coronary
angiography, which was performed within two hours after
syncope. Coronary angiography of the left coronary artery
indicated subocclusive ostial lesion of the left main coronary
artery with TIMI (thrombolysis in myocardial infarction)
grade 2 flow (Figure 2). The right coronary artery was with-
out significant lesions (Figure 3). After consultation with the
cardiac surgeon, because of the possibility for emergency
surgical revascularization, primary percutaneous coronary
Fig. 1 – Electrocardiogram at admission – sinus rhythm,  incomplete left bundle branch block, heart (AV) block 1st degree,
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intervention (pPCI) was performed. Periprocedural heparin
(10,000 IU) was administrated intracoronary. Initial heparin
infusion was stopped. As a result of the developing cardio-
genic shock and lesion of the left main coronary artery, an
intra-aortic balloon pump (IABP) with the ratio 1:1 was im-
planted before the intervention. The following were used in
pPCI: 5F left Judkins guideing catheter 4.0, guidewire
(Runthrough, Terumo Europe) and a drug-eluting stent (No-
bori 3.5 u 14 mm, Terumo Europe).
During cannulation of the left coronary artery, its occlu-
sion occurred as a result of ostial lesion, so immediately be-
fore the intervention, the guidewire was placed with the stent
in the catheter, together cannulating the left coronary artery.
A direct stent was deployed at 14 atm and the primary result
of the intervention was optimal (Figures 4, 5). In order to
prevent acute stent thrombosis, after the stent deployment,
glycoprotein IIb/IIIa inhibitor abciximab was administered
intracoronary, and continued intravenouslly during following
12 hours. After the intervention the patient still had signs of
cardiogenic shock and was supported with the intra-aortic
balloon pump. Right cardiac microcatheterisation was per-
formed through the right interior jugular vein with a pulmo-
nary artery catheter (Swan-Ganz). The value of pulmonary
capillary wedge pressure (PCW) was 8 mmHg. These hemo-
dynamic parameters can be explained with the sedation of
the patient on IMV with PEEP 5 cm H2O, which caused
systemic and pulmonary vasodilatation and lower PCW. Ex-
pansion of the volume was initiated using glucose and elec-
trolyte solutions, along with inotropic stimulation with do-
pamine 8 mcg/kg/min. After this treatment, hemodynamic
stabilisation was achieved (MAP 75 mmHg), PCW increased
to 18 mmHg and diuresis was 150 mL/h. As a result of in-
termittent hemodynamic and respiratory instability, in the
following four days the patient was on IMV in IPPV mode of
ventilation, supported with IABP. After that, the patient was
hemodynamically and respiratory sufficient, so he was extu-
bated and circulatory support was stopped. The intra-aortic
balloon pump removed without haemorrhagic complications.
Carotid arteries ultrasound showed no significant lesions of
carotid arteries. Follow-up echocardiographic examination
showed EF of 45%, anteroseptal hypokinesia with medio-
apical septal akinesia. On the 15th day after admission, the
patient was discharged with the diagnosis of acute anterior
myocardial infarction  (on the basis of electrocardiographic
changes, and later increased levels of hs troponin and CK-
MB, echocardiographic findings and the results of coronary
angiography) (Figure 6), in cardiologically stable condition
with double antiplatelet therapy (aspirin 300 mg, clopidogrel
Fig. 2 – The right anterior oblique (RAO) projection of the
left coronary artery – ostial lesion of the main stem.
Fig. 3 – The left anterior oblique (LAO) projection of the
right coronary artery.
Fig. 4 – Direct implantation of the stent in the ostium of the
left main coronary artery with the support of an intra-aortic
baloon pump.
Fig. 5 – The right anterior oblique (RAO) projection of the
left coronary artery after stent implantation – the optimal
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150 mg), beta-blocker (metoprolol 100 mg), ACE inhibitor
(ramipril 2.5 mg), statin (atorvastatin 20 mg), diuretic (furo-
semid 40 mg) and aldosterone antagonist (spironolactone 25
mg). In the following 12 months the patient was without
subjective complaints. Follow-up echocardiographic exami-
nation showed increased EF of 55%, hypokinesia apical-
septal basal inferior. A stress exercise test using the Bruce
protocol was performed and no signs of reduced coronary
flow were registered. Ambulatory Holter-electroardiography
monitoring showed sinus rhythm, with the average heart rate
69/min, rare ventricular and supraventricular premature
beats. No conduction disorders were detected.
Discussion
Cardiovascular causes are the most common life-
threatening conditions associated with syncope, and these
can be divided into arryhthmogenic, structural, and ische-
mic 
1. Syncope from a sudden disruption in cardiac output is
the deadliest form of syncope. Arrhythmogenic causes of
syncope can include ventricular tachycardia, bradycardia
[e.g. Mobitz type II or 3rd degree heart (AV) block], and
significant sinus pauses (more than 3 seconds). Ischemia in-
cludes acute coronary syndromes, acute myocardial infarc-
tion. Among structural abnormalities are: valvular heart dis-
ease, such as aortic or mitral stenosis, cardiomyopathy (e.g.,
ischemic, dilated, hypertrophic), aortic dissection, atrial
myxoma, and cardiac tamponade 
1. Cardiac syncope more
often occurs in patients older than 45 years. Life-threatening
causes of syncope beside cardiovascular causes, include
hemorrhage, and subarachnoid hemorrhage. Approximately
15% of the following life-threatening conditions present with
syncope: subarachnoid hemorrhage, acute coronary syn-
drome, aortic dissection, leaking aortic aneurysm, and rup-
tured ectopic pregnancy. Many of the missed diagnoses of
these five conditions that resulted in medico-legal action in-
volved presentations that included syncope 
1.
Syncope without chest pain is not the most typical
symptom of acute coronary syndrome. In acute coronary
syndrome, syncope is mostly caused by malignant rhythm
and conduction disorders, and in fewer cases is caused by
large myocardial damage. There is no much literature data on
syncope after acute coronary event as neuromediated reac-
tion. Sympathetic withdrawal seems to be the most likely
mechanism of syncope 
6. In the presented case, the most
probable cause of syncope was cerebral hypoperfusion,
which occurred due to incipient cardiogenic shock, since un-
stable atherosclerotic plaque in the ostium of the left main
stem caused transient myocardial ischemia with lower car-
diac output. Strategies in diagnostic syncope include the pa-
tients history, special tests like carotid sinus massage, tilt-
table tests, echocardiography (ECHO), exercise stress test,
cardiac monitoring, Holter monitor, external loop recorder,
implantable loop recorder and electrophysiologic study. In
emergency cases, like the presented one, for the diagnosis
etiology of syncope were ECG, cardiac monitoring, ECHO
and coronary angiography were important facts. Exercise
stress tests, ambulatory ECG Holter monitor, loop recorders
are important facts for the patient’s follow up.
Emergency echocardiography is an important and use-
ful tool for establishing the diagnosis. That provides diag-
nostic and prognostic information on heart diseases that pre-
dispose patients to syncope, including the assessment of car-
diac size, left-ventricular function, wall motion, valvular
heart disease, pulmonary pressure or right ventricular strain
and pericardial effusions. It has also become an established
tool for diagnosing coronary artery disease 
7.
Following the algorithm for emergency treatment of
cardiovascular patients (ECG, biomarkers, echocardiogra-
phy, and monitoring hemodynamic parameters), the precise
diagnosis of acute myocardial infarction was quickly made
and adequate treatment was provided.  Primary percutaneous
coronary intervention is nowadays an option for treatment of
acute myocardial infarction, and it should be performed by
the center with a large number of patients, which is able to
perform the interventions 24 hours, 7 days a week, 365 days
a year. Concerning treatment of lesions of the left main
coronary artery, surgical myocardial revascularization
Fig. 6 – Electrocardiogram at discharge – sinus rhythm, heart rate 60/min, negative T waves in DI, AVL, V2-V6.Strana 1070 VOJNOSANITETSKI PREGLED Volumen 71, Broj 11
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(CABG) is considered a “golden rule” for the treatment of
unprotected LMCA, but PCI is emerging as a possible alter-
native to surgery in certain groups of patients. Localization
of the lesion is an important factor when considering PCI as
the treatment for unprotected stenosis of the left main coro-
nary artery. Stenting the ostium of the left main stem or me-
dial segment is preferable to distal segment with bifurcation
or trifurcation lesions, which requires a considerable experi-
ence of the operator 
4.  Percutaneous coronary intervention
on bifurcation lesions of the left main stem is accompanied
by a higher incidence of restenosis in comparison with the
ostium or the medial segment 
8. The importance of lesion lo-
calization for the choice of treatment was presented in the
SYNTAX study 
9; for example, patients with left main stem
lesion and SYNTAX score higher than 33, with more com-
plex or extensive coronary disease, have higher mortality
with PCI than with CABG. According to the recommenda-
tions of ACC/AHA from 2009 in treatment of lesions on the
left main stem PCI does not require follow-up coronary an-
giography 
10. Emergency PCI is recommended for unpro-
tected lesion of the left main stem in the treatment of acute
myocardial infarction, with “culprit“ lesions, when antero-
grade flow is compromised, and when the patient is hemody-
namically unstable; it is believed that in these circumstances
PCI may enable a faster outcome than CABG 
11.  Taking all
these facts into account, the treatment using PCI for the said
patient was chosen, because the patient was in the state of
initial cardiogenic shock, the ostial lesion of the left main
coronary artery was suitable for PCI and it was quicker to
treat it in this manner than by using surgical myocardial re-
vascularization.
A drug-eluting stent (DES) was implanted, in the pre-
sented patient because the results of randomised studies
showed that there was a significantly lower rate of major ad-
verse cardiac events (MACE), mortality, and repeated revas-
cularisation after 6 month, 12 months, 2 years and 3 years, in
comparison with bare metal stents (BMS) 
12.
Cardiogenic shock is a cause of a high mortality rate in
patients with acute myocardial infarction. Treatment of car-
diogenic shock as a complication of acute myocardial infarc-
tion includes hemodynamic stability achieved by medication
therapy or circulatory support and emergency revasculariza-
tion using PCI or CABG. Medication therapy includes anti-
platelet and antithrombotic drugs, vasopressors and inotropic
agents. Antiplatelet and antithrombotic therapy should be
done automatically in acute myocardial infarction. Volume
application is often used, although it has not been analyzed
in randomised studies. Vasopressors and inotropic agents are
used because of their positive hemodynamic effect, but nei-
ther of them leads to permanent symptomatic improvement,
and many even reduce survival rate, which may be associ-
ated with cell dysfunction caused by these drugs 
13. A recent
randomised study compared norepinephrine and dopamine in
cardiogenic shock. Dopamine was associated with a higher
mortality rate and more adverse effects, such as arrhyth-
mia 
14. In hypotension with other signs of cardiogenic shock,
norepinephrine is recommended as the first choice. It should
be initially administered in low doses and gradually titrated
until systolic pressure reaches values of over 80 mmHg. Af-
ter that, dobutamine can be administered together with nor-
epinephrine for better contractility 
13. In the presented case,
hemodynamic stability was achieved using dopamine and
volume application.
A SHOCK study 
15 revealed that patients with cardio-
genic shock treated with pPCI or emergency surgical revas-
cularization had better prospects of survival in comparison
with patients with initial medication treatment.
Intra-aortic balloon pump is widely used in the treatment
of cardiogenic shock and it represents the first line of circula-
tory support. A TACTICS study 
5 has shown that IABP does
not contribute to the reduction in intra-hospital mortality, but it
brings about the improvement in a six-month mortality rate. A
IABP-SHOCK II study has shown that the use of intra-aortic
balloon counterpulsation does not significantly reduce a 30-
day mortality in patients with cardiogenic shock complicating
acute myocardial infarction for whom an early revasculariza-
tion strategy was planned 
13, 16. Recent meta-analysis evi-
denced it in relation to survival rate when using IABP in car-
diogenic shock 
17. IABP therapy is considered to be a class IIb
indication (European Society of Cardiology guidelines) for the
management of cardiogenic shock 
13.
Conclusion
This case report shows that the fast diagnosis, espe-
cially in patients with relatively atypical clinical presenta-
tion, and application of reperfusion therapy using percutane-
ous coronary intervention in patients with acute myocardial
infarction complicated by cardiogenic shock, as well as ap-
plication of adequate medication therapy and circulatory and
respiratory support, contribute to the improvement in the
survival rate and the quality of life of such patients.
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